$ATNM "$2.2bn acquisition of Endocyte Inc by Novartis, these data can only add to the excitement around radiopharmaceuticals. One of a handful of pure play clinical stage radio pharma companies, Actinium looks an attractive asset" #Pennystocks #OTCStocks $JNJ $BMY $PFE $SNY $LLY